nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An mRNA vaccine elicits STING-dependent antitumor immune responses
|
Chen, Zhe |
|
|
13 |
3 |
p. 1274-1286 |
artikel |
2 |
A novel IRAK4/PIM1 inhibitor ameliorates rheumatoid arthritis and lymphoid malignancy by blocking the TLR/MYD88-mediated NF-κB pathway
|
Yoon, Sae-Bom |
|
|
13 |
3 |
p. 1093-1109 |
artikel |
3 |
Author correction to “The FAPα-activated prodrug Z-GP-DAVLBH inhibits the growth and pulmonary metastasis of osteosarcoma cells by suppressing the AXL pathway” [Acta Pharm Sin B 12 (2022) 1288–1304]
|
Ye, Geni |
|
|
13 |
3 |
p. 1337-1339 |
artikel |
4 |
Author correction to “TMEM16A inhibits angiotensin II-induced basilar artery smooth muscle cell migration in a WNK1-dependent manner” [Acta Pharm Sin B 11(12) (2021) 3994–4007]
|
Zheng, Huaqing |
|
|
13 |
3 |
p. 1340-1343 |
artikel |
5 |
Compound Danshen Dripping Pill inhibits hypercholesterolemia/atherosclerosis-induced heart failure in ApoE and LDLR dual deficient mice via multiple mechanisms
|
Yang, Yanfang |
|
|
13 |
3 |
p. 1036-1052 |
artikel |
6 |
Concurrent silencing of TBCE and drug delivery to overcome platinum-based resistance in liver cancer
|
Li, Senlin |
|
|
13 |
3 |
p. 967-981 |
artikel |
7 |
Cover Story
|
|
|
|
13 |
3 |
p. xii |
artikel |
8 |
Development of fluorine-substituted NH2-biphenyl-diarylpyrimidines as highly potent non-nucleoside reverse transcriptase inhibitors: Boosting the safety and metabolic stability
|
Jin, Xin |
|
|
13 |
3 |
p. 1192-1203 |
artikel |
9 |
Dihydrofolate reductase-like protein inactivates hemiaminal pharmacophore for self-resistance in safracin biosynthesis
|
Shao, Ning |
|
|
13 |
3 |
p. 1318-1325 |
artikel |
10 |
Discovery of novel phosphodiesterase-1 inhibitors for curing vascular dementia: Suppression of neuroinflammation by blocking NF-κB transcription regulation and activating cAMP/CREB axis
|
Zhou, Qian |
|
|
13 |
3 |
p. 1180-1191 |
artikel |
11 |
Discovery of the radio-protecting effect of Ecliptae Herba, its constituents and targeting p53-mediated apoptosis in vitro and in vivo
|
Wu, Jiang |
|
|
13 |
3 |
p. 1216-1230 |
artikel |
12 |
G protein-coupled receptor 35 attenuates nonalcoholic steatohepatitis by reprogramming cholesterol homeostasis in hepatocytes
|
Wei, Xiaoli |
|
|
13 |
3 |
p. 1128-1144 |
artikel |
13 |
HBXIP blocks myosin-IIA assembly by phosphorylating and interacting with NMHC-IIA in breast cancer metastasis
|
Zhang, Lu |
|
|
13 |
3 |
p. 1053-1070 |
artikel |
14 |
Herbal formula BaWeiBaiDuSan alleviates polymicrobial sepsis-induced liver injury via increasing the gut microbiota Lactobacillus johnsonii and regulating macrophage anti-inflammatory activity in mice
|
Fan, Xiaoqing |
|
|
13 |
3 |
p. 1164-1179 |
artikel |
15 |
Lipid nanomaterials-based RNA therapy and cancer treatment
|
Zhang, Xingcai |
|
|
13 |
3 |
p. 903-915 |
artikel |
16 |
Lipid-polymer hybrid nanoparticle with cell-distinct drug release for treatment of stemness-derived resistant tumor
|
Shen, Shiyang |
|
|
13 |
3 |
p. 1262-1273 |
artikel |
17 |
Membrane dual-targeting probes: A promising strategy for fluorescence-guided prostate cancer surgery and lymph node metastases detection
|
Wu, Ling-Ling |
|
|
13 |
3 |
p. 1204-1215 |
artikel |
18 |
Mitochondrial transplantation as a promising therapy for mitochondrial diseases
|
Zhang, Tian-guang |
|
|
13 |
3 |
p. 1028-1035 |
artikel |
19 |
Mucus-penetrating nonviral gene vaccine processed in the epithelium for inducing advanced vaginal mucosal immune responses
|
Bi, Qunjie |
|
|
13 |
3 |
p. 1287-1302 |
artikel |
20 |
Nanoparticles (NPs)-mediated systemic mRNA delivery to reverse trastuzumab resistance for effective breast cancer therapy
|
Dong, Zhihui |
|
|
13 |
3 |
p. 955-966 |
artikel |
21 |
Nucleic acid nanoassembly-enhanced RNA therapeutics and diagnosis
|
Zhao, Mengnan |
|
|
13 |
3 |
p. 916-941 |
artikel |
22 |
Progress in the studies on the molecular mechanisms associated with multidrug resistance in cancers
|
Zhang, Lei |
|
|
13 |
3 |
p. 982-997 |
artikel |
23 |
Real-time SERS monitoring anticancer drug release along with SERS/MR imaging for pH-sensitive chemo-phototherapy
|
Huang, Xueqin |
|
|
13 |
3 |
p. 1303-1317 |
artikel |
24 |
Recent advances in bacterial therapeutics based on sense and response
|
Feng, Zhuo |
|
|
13 |
3 |
p. 1014-1027 |
artikel |
25 |
Rhodojaponin VI indirectly targets Cav2.2 channels via N-ethylmaleimide-sensitive fusion protein to alleviate neuropathic pain
|
Chen, Keliang |
|
|
13 |
3 |
p. 1326-1336 |
artikel |
26 |
Roles of focal adhesion proteins in skeleton and diseases
|
Chen, Sheng |
|
|
13 |
3 |
p. 998-1013 |
artikel |
27 |
ROS-removing nano-medicine for navigating inflammatory microenvironment to enhance anti-epileptic therapy
|
Zhou, Zheng |
|
|
13 |
3 |
p. 1246-1261 |
artikel |
28 |
Sodium alginate coating simultaneously increases the biosafety and immunotherapeutic activity of the cationic mRNA nanovaccine
|
Duan, Xing |
|
|
13 |
3 |
p. 942-954 |
artikel |
29 |
S1PR1 serves as a viable drug target against pulmonary fibrosis by increasing the integrity of the endothelial barrier of the lung
|
Hao, Mengyao |
|
|
13 |
3 |
p. 1110-1127 |
artikel |
30 |
Table of Contents
|
|
|
|
13 |
3 |
p. iii-xii |
artikel |
31 |
Targeting metabolic vulnerability in mitochondria conquers MEK inhibitor resistance in KRAS-mutant lung cancer
|
Feng, Juanjuan |
|
|
13 |
3 |
p. 1145-1163 |
artikel |
32 |
The deubiquitinating enzyme 13 retards non-alcoholic steatohepatitis via blocking inactive rhomboid protein 2-dependent pathway
|
Xu, Minxuan |
|
|
13 |
3 |
p. 1071-1092 |
artikel |
33 |
The role of phosphatidylcholine 34:1 in the occurrence, development and treatment of ulcerative colitis
|
Yu, Tengjie |
|
|
13 |
3 |
p. 1231-1245 |
artikel |